title: CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia.
authors: Clinical Laboratory and Department of Hematology, University Hospital La Fe, Valencia, Spain barragan_eva@gva.es.
authors: Eva
authors: E
authors: Barragán
authors: Department of Hematology, University Hospital of Salamanca, Salamanca Institute for Biomedical Research (IBSAL), Spain.
authors: María Carmen
authors: MC
authors: Chillón
authors: Program of Hematology-Oncology, CIMA, University of Navarra, Pamplona, Spain.
authors: Remedios
authors: R
authors: Castelló-Cros
authors: Program of Hematology-Oncology, CIMA, University of Navarra, Pamplona, Spain.
authors: Nerea
authors: N
authors: Marcotegui
authors: Department of Hematology, University Hospital of Salamanca, Salamanca Institute for Biomedical Research (IBSAL), Spain.
authors: María Isabel
authors: MI
authors: Prieto
authors: Department of Hematology, Hospital Santa Creu i Sant Pau, Barcelona, Spain.
authors: Montserrat
authors: M
authors: Hoyos
authors: Program of Hematology-Oncology, CIMA, University of Navarra, Pamplona, Spain.
authors: Raffaella
authors: R
authors: Pippa
authors: Clinical Laboratory and Department of Hematology, University Hospital La Fe, Valencia, Spain.
authors: Marta
authors: M
authors: Llop
authors: Program of Hematology-Oncology, CIMA, University of Navarra, Pamplona, Spain.
authors: Amaia
authors: A
authors: Etxabe
authors: Clinical Laboratory and Department of Hematology, University Hospital La Fe, Valencia, Spain.
authors: José
authors: J
authors: Cervera
authors: Department of Hematology, Gregorio Marañón Institute for Health Research, Madrid, Spain.
authors: Gabriela
authors: G
authors: Rodríguez
authors: Department of Hematology, Gregorio Marañón Institute for Health Research, Madrid, Spain.
authors: Ismael
authors: I
authors: Buño
authors: Department of Hematology, Clinical University of Navarra, Pamplona, Spain.
authors: José
authors: J
authors: Rifón
authors: Department of Hematology, Hospital Santa Creu i Sant Pau, Barcelona, Spain.
authors: Jorge
authors: J
authors: Sierra
authors: Department of Hematology, University Hospital of Salamanca, Salamanca Institute for Biomedical Research (IBSAL), Spain.
authors: Marcos
authors: M
authors: González
authors: Department of Biochemistry and Genetics, University of Navarra, Pamplona, Spain.
authors: María J
authors: MJ
authors: Calasanz
authors: Clinical Laboratory and Department of Hematology, University Hospital La Fe, Valencia, Spain.
authors: Miguel A
authors: MA
authors: Sanz
authors: Program of Hematology-Oncology, CIMA, University of Navarra, Pamplona, Spain Department of Biochemistry and Genetics, University of Navarra, Pamplona, Spain.
authors: María D
authors: MD
authors: Odero
mesh_terms: D001324:Autoantigens / Q000235:genetics*; D015870:Gene Expression; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D059785:Karyotype; D015470:Leukemia, Myeloid, Acute / Q000235:genetics* / Q000401:mortality*; D008565:Membrane Proteins / Q000235:genetics*; D011379:Prognosis; D016019:Survival Analysis
chemical_list: D001324:Autoantigens; C500266:CIP2A protein, human; D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins
keywords: CIP2; acute myeloid leukemia; normal karyotype; overall survival; prognosis
references: Blood. 2005 Oct 1;106(7):2452-61
references: 15972450
references: N Engl J Med. 2008 May 1;358(18):1909-18
references: 18450602
references: Clin Cancer Res. 2009 Aug 15;15(16):5092-100
references: 19671842
references: J Clin Oncol. 2011 Feb 10;29(5):475-86
references: 21220609
references: Leukemia. 2011 Apr;25(4):606-14
references: 21233840
references: Int J Lab Hematol. 2011 Jun;33(3):290-8
references: 21219591
references: Leukemia. 2014 Sep;28(9):1915-8
references: 24781014
references: Hematology Am Soc Hematol Educ Program. 2012;2012:1-6
references: 23233553
references: Hematology Am Soc Hematol Educ Program. 2012;2012:28-34
references: 23233557
references: Cancer Discov. 2013 Feb;3(2):182-97
references: 23306062
references: Lancet Oncol. 2013 May;14(6):e229-38
references: 23639323
references: Cancer Res. 2013 Nov 15;73(22):6548-53
references: 24204027
references: Clin Cancer Res. 2014 Apr 15;20(8):2092-103
references: 24436473
references: Haematologica. 2012 Apr;97(4):543-50
references: 22133779